Natixis Zai Lab LTD Call Options Transaction History
Natixis
- $22 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ZLAB
# of Institutions
171Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$173 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$159 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$115 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$63.2 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$45.6 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.81B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...